الاثنين، 13 يونيو 2016

ScienceDaily: Top News

ScienceDaily: Top News


Antibody-based drug helps 'bridge' leukemia patients to curative treatment

Posted: 12 Jun 2016 07:58 AM PDT

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.

ليست هناك تعليقات:

إرسال تعليق